Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Myron Levin to Respiratory Syncytial Virus, Human

This is a "connection" page, showing publications Myron Levin has written about Respiratory Syncytial Virus, Human.

 
Connection Strength
 
 
 
0.861
 
  1. Weinberg A, Lambert SL, Canniff J, Yu L, Lang N, Esser MT, Falloon J, Levin MJ. Antibody and B cell responses to an investigational adjuvanted RSV vaccine for older adults. Hum Vaccin Immunother. 2019; 15(10):2466-2474.
    View in: PubMed
    Score: 0.614
  2. Falloon J, Yu J, Esser MT, Villafana T, Yu L, Dubovsky F, Takas T, Levin MJ, Falsey AR. An Adjuvanted, Postfusion F Protein-Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults. J Infect Dis. 2017 12 12; 216(11):1362-1370.
    View in: PubMed
    Score: 0.139
  3. Levin MJ. Treatment and prevention options for respiratory syncytial virus infections. J Pediatr. 1994 May; 124(5 Pt 2):S22-7.
    View in: PubMed
    Score: 0.108
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)